Life Sciences discovery and research
Discovery, validation, and development in a single proteomics platform
SomaLogic is an industry leader in proteomics, adding new analytes and developing innovative ways to advance your work every single day
Welcome to SomaLogic, the high content proteomic solutions provider for life science research & discovery.
We serve scientists in academia, medical centers, large pharma, biotech and contract research organizations collaborating at the intersections of basic research, disease states and potential clinical applications.
We are excited to support you in gaining new insights into the proteome and the organization and interactions of proteins in living systems to better understand complex biological systems to advance life science research and medicine.
SomaLogic has revolutionized aptamer-based proteomics with the development of our proprietary slow off-rate modified aptamer, or SOMAmer®, protein capture reagents.
Choose from our portfolio of proteomic solutions utilizing slow off-rate aptamers, SOMAmers, for protein capture and quantification in a wide range of complex sample types. We keep it simple by offering a novel technology platform to profile proteins for disease specific research and biological discovery. We boast industry-leading reliability metrics that include higher sensitivity, specificity, and reproducibility, with coefficients of variation less than 5%. Our assays utilize small sample volumes and deliver high-quality, actionable data to accelerate your research.
SomaScan® Assay
For biomarker discovery, assay size is critical.
What is the SomaScan® Assay?
The SomaScan Assay profiles 7,000 different proteins from only 55 μL of plasma/serum. That’s more than double the number of proteins of any other platform on the market.
Key use cases
Biomarker discovery
Mechanism of action
Identification of adverse effects
Sample input requirements
55 μL of plasma/serum
Menu size
7,000 protein epitopes and counting
Assay output
Expression data for each SOMAmer in the assay
Validation
More than 400 peer-reviewed papers have been published using SomaScan technology, with over 450,000 samples tested since 2010.
SomaSignal® Tests
For clinical trial monitoring, actionable reporting is key.
What are SomaSignal® Tests?
SomaSignal® Tests deliver clinically relevant information about patient health and risk status derived by comparing clinical data and SomaScan data.
Key use cases
Easy sampling facilitates longitudinal studies
Risk assessment score for specific pathologies
Real-time readout of physical state and trajectory
Sample input requirements
55 μL of plasma/serum
Menu size
21 validated tests and growing
Assay output
Risk profile of disease likelihood, probability, and/or severity of phenotype
Validation
SomaSignal Tests use proteomic expression algorithms validated with patient cohorts in clinical studies.
Download the SomaScan Assay brochure
View highlights of the SomaScan Assay for protein profiling and biomarker discovery in a variety of diseases including oncology, neurology and cardiovascular disease.
Choose from
SomaScan® Assay services
Measure over 7,000 proteins in a variety of samples including plasma, serum, CSF and others.
SomaLogic certified site
Bring the SomaScan® 7K Assay to your own lab with our scientific support.
SomaScan® panels
Study associated protein families in a range of disease states including curated panels for Neurobiology, Oncology, Cardiovascular Disease and more or create your own customized panels.
SomaSignal® Test
Choose from 21 specific tests from our growing menu.
Your samples yield valuable insights, gain new proteomic insights with data that provides the best in class AI and scientific support from your SomaLogic team.